BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Oncolytics Biotech Inc. 

210-1167 Kensington Crescent

Calgary  Alberta  T2N 1X7  Canada
Phone: 403-670-7374 Fax: 403-283-0858


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Oncolytics Biotech Inc. (ONC.TO) Presents At The 2015 Immune Checkpoint Inhibitors Meeting 3/26/2015 1:17:57 PM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Status From The European Medicines Agency For Ovarian Cancer 3/25/2015 6:22:39 AM
Oncolytics Biotech Inc. (ONC.TO) Announces 2014 Year End Results 3/17/2015 10:31:06 AM
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Preclinical Data On The Combination Of REOLYSIN And Radiotherapy In Melanoma At The Irish Association For Cancer Research Conference 3/5/2015 9:26:46 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Primary Peritoneal Cancer 3/3/2015 7:01:22 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Cancer Of The Fallopian Tube 3/2/2015 6:57:42 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Completion Of Enrollment In Randomized Phase 2 Colorectal Cancer Study 2/18/2015 7:36:50 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Pancreatic Cancer 2/17/2015 7:48:38 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Ovarian Cancer 2/11/2015 7:40:14 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Filing For Orphan Drug Designation With The U.S. FDA For High Grade Gliomas In Pediatric Patients 2/9/2015 8:48:52 AM
12345678910...